Manufacturer record
Regent Ajanta Biotech 86-87: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Regent Ajanta Biotech 86-87 (Uttarakhand) were declared Not of Standard Quality in June 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: PRT2601-29, Telmisartan Tablets IP 20mg (exp Dec 2027). SDTL, Guwahati (state lab) found it not of standard quality: The sample does not conform to I.P. w.r.to the tests for Dissolution. Listed in the June 2026 alert.
Records by type
3 records linked to Regent Ajanta Biotech 86-87 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Telmisartan Tablets IP 20mg | Batch PRT2601-29Mfg Jan 2026 · Exp Dec 2027 | The sample does not conform to I.P. w.r.to the tests for DissolutionDissolution | SDTL, GuwahatiState lab | Jun 2026 |
| Telmisartan Tablets IP 20mg | Batch PRT2601-30Mfg Jan 2026 · Exp Dec 2027 | The sample does not conform to I.P. w.r.to the tests for DissolutionDissolution | SDTL, GuwahatiState lab | Jun 2026 |
| Telmisartan & Amlodipine Besylate Tablets IP | Batch PRT2602-149Mfg Feb 2026 · Exp Jan 2028 | The sample does not conform to I.P. w.r.to the tests for DissolutionDissolution | SDTL, GuwahatiState lab | Jun 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.